Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Ohio Passes Antidiscrimination Provision for CRNA Reimbursement

Client Alert

The passage of Ohio House Bill 96 (HB 96), which sets forth the state’s operating budget, includes important legislation regarding certified registered nurse anesthetists (CRNAs). Health benefit plans will soon be required to pay CRNAs at the same reimbursement rate as their physician counterparts for performing the same service. The new law seeks to promote patient access to care by prohibiting discrimination against CRNAs acting within the scope of their licensure. In recent years, CRNAs have faced payment discrimination from certain insurers who reduced their reimbursement rate from 100% to 85%, or who prohibited CRNA reimbursement altogether, based on their status as non-physician practitioners. Meanwhile, physician anesthesiologists are reimbursed at 100% for providing the same care.

Advocates for provider nondiscrimination have argued that discrimination based on provider licensure keeps patients from accessing the care they need. Ohio’s new law is an attempt to remedy this barrier to patient care while ensuring CRNAs are paid equally for performing the same tasks as physician anesthesiologists.

Ohio joins several other states who have enacted similar legislation for payment equality among providers rendering the same service including Maine[1], Virginia[2], Delaware[3], and New Hampshire[4]. This legislation does not prevent insurers from establishing variable reimbursement rates based on quality or performance measures. The new law will go into effect on September 30, 2025.

If you have any questions about the impact of HB 96 on CRNA reimbursement, please contact BMD Member Jeana Singleton at jmsingleton@bmdllc.com or Attorney Kate Crawford at khcrawford@bmdllc.com.

[1] 24-A MRSA §4320-Q

[2] VA Code Ann. § 38.2-3408

[3] 19 DE Admin. Code 1341-4.11

[4] N.H. Rev. Stat. § 420-J:8(VIII)(f)


CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule with Key Payment and Telehealth Updates

CMS issued the CY 2026 Medicare Physician Fee Schedule Final Rule on October 31, 2025, with changes effective January 1, 2026. The Final Rule includes increases to the conversion factor, a new efficiency adjustment, updates to practice expense methodology, permanent telehealth policy changes, revised payment for skin substitutes, expanded rules for Part B drugs and biologicals, enhanced policies for Rural Health Clinics and Federally Qualified Health Centers, and new care management and behavioral health services.

Ohio Department of Medicaid Updates: Key Changes to Physician Reimbursement Rates in Early Parenthood

The Ohio Department of Medicaid has proposed amending Ohio Administrative Code Rule related to covered Medicaid reimbursements for physicians. Beginning on January 1, 2026, they are proposing an increase to rates for prenatal care, childbirth, and infant care and provider visits.

Name, Image, and Likeness Agreements in Healthcare

For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.

Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.

Top Compliance Risks for Ohio Med-Spas in 2025

The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.